D KEITH GROSSMAN
CIK 1218702 · Executive Chairman · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.39M
Companies
9
Total Filings
116
Lifetime Open-Market Net
-$10.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OM | Director | 37,430 | $4.69 | $175.5K | -$1.10M | 19 | 2026-06-05 |
| MMED | Director | 13,889 | $18.30 | $254.2K | $0 | 1 | 2026-03-11 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | $939.0K | 43 | 2025-04-03 |
| ViewRay, Inc. (VRAY) Delisted | Director | 100,855 | $0.03 | $2.5K | $0 | 6 | 2021-01-05 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 0 | — | — | $0 | 6 | 2017-04-28 |
| THORATEC CORP (THOR) Delisted | President & Chief Exec Officer | 602,050 | — | — | -$2.32M | 20 | 2015-10-08 |
| CONCEPTUS INC (CPTS) Delisted | President & CEO | 204,882 | — | — | $0 | 3 | 2013-02-11 |
| ISRG | Director | 36,450 | $355.63 | $12.96M | -$8.12M | 13 | 2010-04-23 |
| KYPHON INC (KYPH) Delisted | Director | 64 | — | — | $0 | 2 | 2007-05-09 |
Recent Filings · Page 4 of 12
116 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-28 | NEVRO CORP (NVRO) Delisted | Mixed | +69,910 | -$5.21M | EDGAR |
| 2022-03-21 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,875 | -$344.2K | EDGAR |
| 2022-03-15 | NEVRO CORP (NVRO) Delisted | Tax (F) | −2,754 | -$176.5K | EDGAR |
| 2022-03-08 | NEVRO CORP (NVRO) Delisted | Buy (P) | +3,200 | $203.5K | EDGAR |
| 2022-03-08 | NEVRO CORP (NVRO) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2022-03-07 | NEVRO CORP (NVRO) Delisted | Grant (A) | −50,000 | $0 | EDGAR |
| 2021-12-21 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,874 | -$418.2K | EDGAR |
| 2021-12-02 | OM | Sell (S) | −1,296 | -$62.1K | EDGAR |
| 2021-11-02 | OM | Sell (S) | −3,888 | -$212.9K | EDGAR |
| 2021-10-04 | OM | Mixed | −1,234 | -$64.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.